Velentium vs Jabil Healthcare: full comparison for 2026
Quick verdict
Velentium (4.5/5) edges ahead of Jabil Healthcare (3.8/5) overall. Velentium is the better choice for implantables and FDA cybersecurity submissions. Jabil Healthcare is the stronger option for global production capacity for cleared devices. The right choice depends on your project size, budget, and required tech stack.
Velentium vs Jabil Healthcare: head-to-head summary
| Criterion | Velentium | Jabil Healthcare |
|---|---|---|
| Founded | 2012 | 1966 |
| HQ | Katy, TX, USA | St. Petersburg, FL, USA |
| Team size | 51–250 | ~20,000 (healthcare) |
| Rating | 4.5 / 5 | 3.8 / 5 |
| Primary differentiator | Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation | Global scale, supply chain and FDA-registered production for established medical device brands |
| Pricing model | Fixed project, time and materials, manufacturing contract | Manufacturing supply agreement, NPI contract |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Embedded C/C++, RTOS, BLE | Injection molding, Automated assembly, PCB assembly |
| Industries served | Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring | Surgical & robotics, Drug delivery, Wearables & remote monitoring, Consumer health |
Velentium vs Jabil Healthcare: overview
Velentium
Velentium was founded in 2012 and is based in Katy, near Houston, Texas. It designs, develops and manufactures active medical devices, including implantables and their programmers, and offers systems engineering, firmware, software, cybersecurity and CGMP manufacturing. Great Point Partners completed a growth recapitalization in 2021, the company sold its oil and gas division in 2023 to focus fully on medtech, and it took $15M in growth financing from Trinity Capital in 2024. Headcount estimates range from 51 to 250.
Jabil Healthcare
Jabil Healthcare was formed in 2020 when Jabil combined its Nypro business with its orthopedics, spine and trauma units. At launch it had nearly 20,000 employees and more than 35 sites, and its factories producing finished medical devices are FDA registered. It covers minimally invasive devices, surgical robotics, complex catheters, diabetes care and consumer health, and the acquisition of CDMO Pii extended it into drug development and aseptic fill-finish. Jabil reported $8.3 billion in company-wide revenue for its second fiscal quarter of 2026.
Services and capabilities: Velentium vs Jabil Healthcare
| Capability | Velentium | Jabil Healthcare |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✗ |
| SaMD & companion apps | ✗ | ✗ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✗ | ✗ |
| Mechanical engineering | ✗ | ✓ |
| Device cybersecurity | ✓ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✓ | ✓ |
Tech stack comparison: Velentium vs Jabil Healthcare
| Framework / platform | Velentium | Jabil Healthcare |
|---|---|---|
| Embedded C/C++ | ✓ | N/A |
| Embedded Linux | N/A | N/A |
| RTOS | ✓ | N/A |
| BLE | ✓ | N/A |
| Cloud (AWS/Azure) | N/A | N/A |
| IEC 62304 | ✓ | N/A |
| ISO 14971 | ✓ | N/A |
| ISO 13485 QMS | N/A | ✓ |
| Qt | N/A | N/A |
Pricing comparison: Velentium vs Jabil Healthcare
| Criterion | Velentium | Jabil Healthcare |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Fixed project, Manufacturing contract, Time & materials | Manufacturing contract |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Velentium vs Jabil Healthcare
| Dimension | Velentium | Jabil Healthcare |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring | Surgical & robotics, Drug delivery, Wearables & remote monitoring |
| Best use cases | Building a neurostimulator and its clinician programmer, Preparing the cybersecurity section of an FDA 510(k) or PMA | Scaling production of a cleared diabetes device, Global manufacturing of a surgical robotics subsystem |
| Typical project type | Fixed project | Manufacturing contract |
Velentium vs Jabil Healthcare: pros and cons
| Velentium | |
|---|---|
| + | Cybersecurity is a full practice here, covering threat modeling, SBOMs, testing and postmarket monitoring |
| + | Experience with active implantable devices, one of the hardest device categories to engineer and certify |
| + | Can manufacture Class II and III devices after development, reducing transfer risk |
| + | Offers training on device cybersecurity, which helps client teams keep up after hand-off |
| - | Private-equity recapitalization and debt financing mean ownership priorities may shift over time |
| - | Smaller than the large consultancies, so very broad programs may stretch the team |
| - | Industrial design and human factors are not its main strength |
| Jabil Healthcare | |
|---|---|
| + | One of the largest healthcare manufacturing networks in the world |
| + | FDA-registered sites for finished devices |
| + | Strong supply chain management during component shortages |
| + | Covers drug delivery through the Pii acquisition |
| - | Built for production volume; early design and invention are outside its main business |
| - | Small companies may struggle to get attention |
| - | Engineering support is tied to manufacturing programs |
Who should choose Velentium?
A typical fit: building a neurostimulator and its clinician programmer.
Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation. Minimum engagement is not publicly disclosed. Works best with clients in Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring.
Who should choose Jabil Healthcare?
A typical fit: scaling production of a cleared diabetes device.
Global scale, supply chain and FDA-registered production for established medical device brands. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & robotics, Drug delivery, Wearables & remote monitoring, Consumer health.
Decision matrix: Velentium vs Jabil Healthcare
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Velentium |
| You need a large dedicated team for an ongoing programme | Check each company's engagement model |
| Your budget is at the lower end | Compare: Velentium (Not disclosed) vs Jabil Healthcare (Not disclosed) |
| You need specialist depth in a specific vertical | Jabil Healthcare |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Velentium vs Jabil Healthcare
| Use case | Velentium fit | Jabil Healthcare fit | Winner |
|---|---|---|---|
| Building a neurostimulator and its clinician programmer | Strong | Limited | Velentium |
| Preparing the cybersecurity section of an FDA 510(k) or PMA | Strong | Limited | Velentium |
| Scaling production of a cleared diabetes device | Limited | Strong | Jabil Healthcare |
| Global manufacturing of a surgical robotics subsystem | Limited | Strong | Jabil Healthcare |
Verdict: Velentium vs Jabil Healthcare
Velentium (4.5/5) is the stronger overall choice for most Medical Device Development projects. Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation.
Jabil Healthcare (3.8/5) is worth a look if you need global manufacturing of a surgical robotics subsystem. If your situation matches that, Jabil Healthcare is a competitive option.
Related comparisons
Velentium vs Jabil Healthcare FAQ
Is Velentium better than Jabil Healthcare?
Velentium (4.5/5) scores higher overall, but "better" depends on your use case. Velentium's strongest advantage: cybersecurity is a full practice here, covering threat modeling, SBOMs, testing and postmarket monitoring. Jabil Healthcare's strongest advantage: one of the largest healthcare manufacturing networks in the world.
How do Velentium and Jabil Healthcare differ in pricing?
Velentium uses fixed project, time and materials, manufacturing contract pricing. Jabil Healthcare uses manufacturing supply agreement, npi contract pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Velentium or Jabil Healthcare?
Velentium is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Velentium and Jabil Healthcare?
Velentium's primary differentiator is: combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation. Jabil Healthcare's primary differentiator is: global scale, supply chain and FDA-registered production for established medical device brands. They also differ in team size (51–250 vs ~20,000 (healthcare)), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Implantables & neuromodulation, Surgical & therapeutic devices vs Surgical & robotics, Drug delivery).
Verify all details directly with each company before making a decision.